Schedule 13G ownership disclosure
Agios Pharmaceuticals Inc
Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 00847X104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Farallon Capital Partners, L.P.
Shares: 422,479 · Class: 0.7%
- Farallon Capital Institutional Partners, L.P.
Shares: 480,410 · Class: 0.8%
- Farallon Capital Institutional Partners II, L.P.
Shares: 141,724 · Class: 0.2%
- Farallon Capital Institutional Partners III, L.P.
Shares: 52,905 · Class: 0.1%
- Four Crossings Institutional Partners V, L.P.
Shares: 97,097 · Class: 0.2%
- Farallon Capital Offshore Investors II, L.P.
Shares: 866,239 · Class: 1.5%
- Farallon Capital (AM) Investors, L.P.
Shares: 62,523 · Class: 0.1%
- Farallon Capital F5 Master I, L.P.
Shares: 222,073 · Class: 0.4%
- Farallon Healthcare Partners Master, L.P.
Shares: 3,329,016 · Class: 5.8%
- Farallon Partners, L.L.C.
Shares: 5,452,393 · Class: 9.6%
- Farallon Institutional (GP) V, L.L.C.
Shares: 97,097 · Class: 0.2%
- Farallon F5 (GP), L.L.C.
Shares: 222,073 · Class: 0.4%
- Farallon Healthcare Partners (GP), L.L.C.
Shares: 3,329,016 · Class: 5.8%
- Dapice Joshua J.
Shares: 5,674,466 · Class: 9.9%
- Dreyfuss, Philip D.
Shares: 5,674,466 · Class: 9.9%
- Dunn Hannah E.
Shares: 5,674,466 · Class: 9.9%
- Fried, Richard B
Shares: 5,674,466 · Class: 9.9%
- Gehani, Varun N.
Shares: 5,674,466 · Class: 9.9%
- Giauque, Nicolas
Shares: 5,674,466 · Class: 9.9%
- Kim, David T.
Shares: 5,674,466 · Class: 9.9%
- Linn, Michael G.
Shares: 5,674,466 · Class: 9.9%
- Luo Patrick (Cheng)
Shares: 5,674,466 · Class: 9.9%
- Patel, Rajiv A.
Shares: 5,674,466 · Class: 9.9%
- Roberts, Jr., Thomas G.
Shares: 5,674,466 · Class: 9.9%
- Saito Edric C.
Shares: 5,674,466 · Class: 9.9%
- Seybold, William
Shares: 5,674,466 · Class: 9.9%
- Short Daniel S.
Shares: 5,674,466 · Class: 9.9%
- Spokes, Andrew J. M.
Shares: 5,674,466 · Class: 9.9%
- Warren, John R.
Shares: 5,674,466 · Class: 9.9%
- Wehrly, Mark C.
Shares: 5,674,466 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-25-000038
- Form type
- SCHEDULE 13G/A
- Filer
- AGIOS PHARMACEUTICALS, INC.
- CIK
- CIK 1439222
- Filed
- Feb 04, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership